BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22456231)

  • 1. Novel intrapleural therapies for malignant diseases.
    Haas AR; Sterman DH
    Respiration; 2012; 83(4):277-92. PubMed ID: 22456231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma.
    Tsao AS; Mehran R; Roth JA
    Clin Lung Cancer; 2009 Jan; 10(1):36-41. PubMed ID: 19289370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts in malignant pleural mesothelioma.
    Kaufman AJ; Pass HI
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignant pleural mesothelioma in 1997].
    Viallat JR; Boutin C; Kasseyet S
    Schweiz Med Wochenschr; 1997 Oct; 127(41):1707-11. PubMed ID: 9441378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis by intrapleural perfusion hyperthermo-chemotherapy for malignant pleural mesothelioma.
    Matsuzaki Y; Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Ann Thorac Cardiovasc Surg; 2008 Jun; 14(3):161-5. PubMed ID: 18577894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?
    Agrawal A; Chaddha U; Shojaee S; Maldonado F
    Semin Respir Crit Care Med; 2023 Aug; 44(4):462-467. PubMed ID: 37308112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapleural immunotherapy: An update on emerging treatment strategies for pleural malignancy.
    Murthy V; Katzman D; Sterman DH
    Clin Respir J; 2019 May; 13(5):272-279. PubMed ID: 30810270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of malignant pleural mesothelioma--present status and future view].
    Yano T; Morodomi Y; Ito K; Miura N; Takenaka T; Kawano D; Shoji F; Maehara Y
    Fukuoka Igaku Zasshi; 2008 Apr; 99(4):74-9. PubMed ID: 18646592
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytokine gene therapy for malignant pleural mesothelioma.
    Vachani A; Sterman DH; Albelda SM
    J Thorac Oncol; 2007 Apr; 2(4):265-7. PubMed ID: 17409795
    [No Abstract]   [Full Text] [Related]  

  • 11. Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion.
    Matsuzaki Y; Shibata K; Yoshioka M; Inoue M; Sekiya R; Onitsuka T; Iwamoto I; Koga Y
    Ann Thorac Surg; 1995 Jan; 59(1):127-31. PubMed ID: 7818311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy in combination with whole-body hyperthermia in advanced malignant pleural mesothelioma].
    Bakhshandeh A; Bruns I; Eberhardt K; Wiedemann GJ
    Dtsch Med Wochenschr; 2000 Mar; 125(11):317-9. PubMed ID: 10761473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
    Sterman DH; Recio A; Carroll RG; Gillespie CT; Haas A; Vachani A; Kapoor V; Sun J; Hodinka R; Brown JL; Corbley MJ; Parr M; Ho M; Pastan I; Machuzak M; Benedict W; Zhang XQ; Lord EM; Litzky LA; Heitjan DF; June CH; Kaiser LR; Vonderheide RH; Albelda SM; Kanther M
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4456-66. PubMed ID: 17671130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesothelioma: path to multimodality treatment.
    Su S
    Semin Thorac Cardiovasc Surg; 2009; 21(2):125-31. PubMed ID: 19822284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotherapy and malignant mesothelioma: clinical perspectives].
    Grégoire M; Ebstein F
    Bull Cancer; 2007 Jan; 94(1):23-31. PubMed ID: 17237002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant mesothelioma 2008.
    Zervos MD; Bizekis C; Pass HI
    Curr Opin Pulm Med; 2008 Jul; 14(4):303-9. PubMed ID: 18520263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
    Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy for malignant pleural mesothelioma.
    Keller SM
    Chest Surg Clin N Am; 1994 Feb; 4(1):127-35. PubMed ID: 8055277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma.
    Xia H; Karasawa K; Hanyu N; Chang TC; Okamoto M; Kiguchi Y; Kawakami M; Itazawa T
    Int J Hyperthermia; 2006 Nov; 22(7):613-21. PubMed ID: 17079218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.